Certain strategies are needed to improve clinical trial diversity, focusing on building patient trust, increasing workforce representation, and reducing logistical burdens.
Kathie-Ann Joseph, MD, MPH, FACS
Advertisement
Articles by Kathie-Ann Joseph, MD, MPH, FACS
Kathie-Ann Joseph, MD, MPH, FACS, described the clinical criteria for nipple-sparing mastectomies and oncoplastic surgery, focusing on tumor-to-nipple distance and oncologic safety for breast cancer patients.
Kathie-Ann Joseph, MD, MPH, FACS, explored evolving surgical strategies for inflammatory breast cancer and phyllodes tumors.
Advertisement
Latest Updated Articles
Building Trust and Removing Barriers in Clinical Trial DiversityFebruary 8th 2026
Advertisement
Advertisement
Trending on CancerNetwork
1
Which Novel Drug Classes Hold Promise in Multiple Myeloma Therapy?
2
Investigators to Discontinue Trial of Eftilagimod Alfa in Frontline NSCLC
3
From Blunt Instruments to Molecular Precision: 40 Years of Oncology Evolution
4
FDA Type B Meeting Appears Successful for Givastomig in Gastric Cancers
5